Mayne Pharma Group Ltd - Asset Resilience Ratio

Latest as of June 2025: 4.00%

Mayne Pharma Group Ltd (MYX) has an Asset Resilience Ratio of 4.00% as of June 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Check Mayne Pharma Group Ltd strategic capital allocation to assess the company's strategic physical and investment asset allocation.

Liquid Assets

AU$40.56 Million

≈ $28.70 Million USD Cash + Short-term Investments

Total Assets

AU$1.01 Billion

≈ $717.90 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2013–2025)

This chart shows how Mayne Pharma Group Ltd's Asset Resilience Ratio has changed over time. See MYX equity financing ratio to measure how much of total assets are equity-financed.

Liquid Assets Composition Over Time

This chart breaks down Mayne Pharma Group Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Mayne Pharma Group Ltd stock valuation.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	AU$0.00	0%
Short-term Investments	AU$40.56 Million	4.0%
Total Liquid Assets	AU$40.56 Million	4.00%

Asset Resilience Insights

Limited Liquidity: Mayne Pharma Group Ltd maintains only 4.00% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Mayne Pharma Group Ltd Industry Peers by Asset Resilience Ratio

Compare Mayne Pharma Group Ltd's asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Sigma Healthcare Ltd AU:SIG	Medical Distribution	0.03%
Jointown Pharmaceutical Group Co Ltd SHG:600998	Medical Distribution	0.08%
Arjo AB (publ) ST:ARJO-B	Medical Distribution	0.18%
Ebos Group Ltd AU:EBO	Medical Distribution	0.00%
Paragon Care Ltd AU:PGC	Medical Distribution	0.00%
Cyclopharm Ltd AU:CYC	Medical Distribution	1.98%
Profarma Distribuidora de Produtos Farmacêuticos S.A SA:PFRM3	Medical Distribution	4.48%
Shanghai Pharmaceuticals Holding Co Ltd SHG:601607	Medical Distribution	4.21%

Annual Asset Resilience Ratio for Mayne Pharma Group Ltd (2013–2025)

The table below shows the annual Asset Resilience Ratio data for Mayne Pharma Group Ltd.

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2025-06-30	4.00%	AU$40.56 Million ≈ $28.70 Million	AU$1.01 Billion ≈ $717.90 Million	+0.57pp
2024-06-30	3.43%	AU$39.21 Million ≈ $27.74 Million	AU$1.14 Billion ≈ $808.87 Million	-6.79pp
2023-06-30	10.22%	AU$127.53 Million ≈ $90.23 Million	AU$1.25 Billion ≈ $882.58 Million	+0.32pp
2022-06-30	9.90%	AU$127.53 Million ≈ $90.23 Million	AU$1.29 Billion ≈ $911.29 Million	+9.87pp
2019-06-30	0.03%	AU$563.00K ≈ $398.36K	AU$1.64 Billion ≈ $1.16 Billion	-0.33pp
2018-06-30	0.37%	AU$6.75 Million ≈ $4.77 Million	AU$1.83 Billion ≈ $1.30 Billion	+0.04pp
2017-06-30	0.32%	AU$6.21 Million ≈ $4.39 Million	AU$1.91 Billion ≈ $1.35 Billion	+0.10pp
2016-06-30	0.22%	AU$3.46 Million ≈ $2.45 Million	AU$1.56 Billion ≈ $1.10 Billion	-0.20pp
2015-06-30	0.42%	AU$2.23 Million ≈ $1.58 Million	AU$528.95 Million ≈ $374.26 Million	-0.02pp
2014-06-30	0.44%	AU$1.17 Million ≈ $829.26K	AU$265.82 Million ≈ $188.08 Million	-0.34pp
2013-06-30	0.78%	AU$1.82 Million ≈ $1.29 Million	AU$233.39 Million ≈ $165.14 Million	--

pp = percentage points

About Mayne Pharma Group Ltd

AU:MYX Australia Medical Distribution

Market Cap

$135.09 Million

AU$190.93 Million AUD

Market Cap Rank

#18130 Global

#556 in Australia

Share Price

AU$2.35

Change (1 day)

+0.00%

52-Week Range

AU$2.13 - AU$6.30

All Time High

AU$41.75